FOLLOW US

Endocrinology Overview

Sprinter stays positive after treatment for papillary thyroid cancer
Though he was redshirted with a foot injury in 2010 and diagnosed with papillary thyroid cancer in December of that year, collegiate sprinter Jeff Gudaitis has been recovering well and staying positive.
Protein tests predict recurrence of papillary or follicular thyroid cancer
Some experts are unsure of the ability of protein-based tests to predict the return of thyroid carcinomas, which is why a team of scientists recently monitored the recurrence of papillary thyroid cancer (PTC) or follicular thyroid cancer (FTC) among patients given serum thyroglobulin (Tg) assays.
Thyroid cancer co-occurs with Hashimoto's thyroiditis more often than with Graves' disease
Individuals with autoimmune thyroid diseases tend to have a higher risk of developing cancer of the gland, which is one reason why researchers at Japan's Ito Hospital recently tabulated the incidence of thyroid tumors among patients with Graves' disease (GD) or Hashimoto's thyroiditis (HT).
Scientists explore how thyroid cancer metastasizes, often staying dormant for years
Distant metastases of thyroid cancer can dramatically reduce a patient's likelihood of survival, which is one reason why a scientist at the Ohio State University College of Medicine recently reviewed the current clinical understanding of how thyroid carcinoma cells migrate.
Macrocephaly points to likelihood of PTEN mutation in follicular thyroid cancer patients
Among people with a mutation of a particular gene called PTEN, the rate of differentiated thyroid cancer (DTC) is between 3 and 10 percent, but until recently, researchers had not tabulated how many patients with follicular thyroid cancer (FTC) typically display the mutation.
Studies summarize promising innovations in molecular diagnosis of thyroid cancer
Two recently released studies, one written by a pair of Greek endocrinologists and the other by an American pathologist, summarize the latest advancements made into the molecular analysis and diagnosis of thyroid cancer.
Researchers assess causes of death among those who succumb to well-differentiated thyroid cancer
While well-differentiated thyroid cancer (WDTC) tends to have a high post-surgical survival rate, individuals who have been treated for this form of thyroid disease occasionally die nonetheless, and a team of New York researchers recently attempted to determine the reasons why.
Genetic changes in thyroid cancer block vitamin D3 absorption in tumor cells
A recent letter to the editor of the journal Thyroid commented on the apparent connection between papillary thyroid cancer (PTC) and the overexpression of the CYP24A1 gene, which codes for enzymes that deactivate vitamin D3.
Study examines occult medullary thyroid cancer
Medullary thyroid cancer (MTC) is a relatively rare form of thyroid disease, one that is often difficult to detect, which is one reason why scientists at the Johns Hopkins University School of Medicine recently attempted to quantify the rate at which MTC goes undiscovered until a thyroidectomy.
Studies recommend maintaining current protocol for radioactive iodine treatment of thyroid cancer
Though a significant body of research recommends that all patients who have been given radioactive iodine 131 (I-131) for thyroid cancer be hospitalized overnight, two new studies suggest keeping the procedure outpatient.
Antibody test predicts risk of thyroid disease after pregnancy
Women who are pregnant have a moderate risk of suffering from postpartum thyroid disease, which is why a Czech group of clinicians and biotechnicians recently tested the rate at which patients with a particular antibody develop thyroid problems after giving birth.
Medication for hypothyroidism may boost fracture risk
Elderly patients taking levothyroxine for hypothyroidism may be at an increased risk for bone fractures, according to a new report released by the University of Toronto.
Case report describes misdiagnosis of papillary thyroid cancer
The importance of correctly pinpointing papillary thyroid cancer (PTC) was recently highlighted in a case report describing the misdiagnosis of the disease as carcinoma of the lungs.
Medicines may one day target papillary thyroid cancer based on its genetic source
Given that thyroid cancer is a disease that originates in mutations of DNA, an Italian researcher recently reviewed the state of genomic medicine, a healthcare field that has the potential to treat malignancies at the genetic level.
In mildest cases of thyroid cancer, radioactive iodine therapy may be unnecessary
While radioactive iodine is routinely prescribed to treat many forms of thyroid cancer, a group of New York researchers stated that this therapy may be unnecessary or even dangerous among patients with the mildest forms of the disease.

Don't Miss Out! Get the FREE EndocrineWeb eNewsletter!

Sign up to receive treatment and research updates, news, and helpful tips on managing your condition.
SUBSCRIBE
close X
SHOW MAIN MENU
SHOW SUB MENU